Clinical and hormonal studies in precocious puberty.
Data from 31 children, 23 females (74.2%) and eight males (25.8%) with precocious puberty were analysed. They included 19 cases with central precocious puberty, 5 with premature thelarche, 5 with premature adrenarche and 1 each with adrenal adenoma and virilizing hepatoblastoma. Their clinical and hormonal profile and the treatment outcome are briefly discussed.
Khandekar
S
S
Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh.
Dash
R J
RJ
D000726:Androgen Antagonists / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D011629:Puberty, Precocious / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
D000726:Androgen Antagonists; D000814:Aniline Compounds; D007166:Immunosuppressive Agents; D017373:Cyproterone Acetate; C050795:N,N-dimethyl-4-anisidine; D017258:Medroxyprogesterone Acetate; D003534:Cyproterone; D008525:Medroxyprogesterone